Stem Cell Therapy to Improve the Muscle Function of Patients With Partly Denervated Muscles of the Arm
Autologous Bone Marrow Transplantation for Muscle Improvement in Traumatic Brachial Plexus Injuries
Study Overview
Status
Status
Conditions
Conditions
Intervention / Treatment
Intervention / Treatment
Detailed Description
Study Type
Study Type
Enrollment (Anticipated)
Enrollment
Phase
Phase
- Phase 2
- Phase 1
Contacts and Locations
Study Contact
Study Contact
- Name: Rob GHH Nelissen, MD, PhD
- Phone Number: 0031715263606
- Email: r.g.h.h.nelissen@lumc.nl
Study Locations
-
-
-
Leiden, Netherlands, 2300RC
- Recruiting
- Leiden University Medical Center
-
Contact:
- Rob GHH Nelissen, MD, PhD
- Phone Number: 0031715263606
- Email: r.g.h.h.nelissen@lumc.nl
-
Contact:
- Bouke J Duijnisveld, MD, MSc
- Phone Number: 0031715263606
- Email: b.j.duijnisveld@lumc.nl
-
Principal Investigator:
- Rob GHH Nelissen, MD, PhD
-
Sub-Investigator:
- Bouke J Duijnisveld, MD, MSc
-
-
Participation Criteria
Eligibility Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Genders Eligible for Study
Description
Inclusion Criteria:
- BP patients with paresis of m. biceps brachii (MRC 1,2,3), either after conservative treatment or at least two years after nerve surgery with partial recovery of the elbow flexor
- Patients capable and willing to give informed consent
Exclusion Criteria:
- Function recovery of the elbow flexor (m. biceps brachii) to a MRC motor scale of 0
- EMG activity: no motor unit potentials
- Medical history of other central of peripheral neurological disorders
- Inability to undergo BM harvesting
- Bleeding diathesis, INR > 2
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Treatment
- Allocation: Non-Randomized
- Interventional Model: Parallel Assignment
- Masking: None (Open Label)
Number of Arms
Arms and Interventions
Participant Group / ArmParticipant Group / Arm |
Intervention / TreatmentIntervention / Treatment |
|---|---|
|
Experimental: A
|
350 ml bone marrow will be aspirated from the posterior iliac crest under general anesthesia in combination with a muscle tendon transposition surgery.
Next, the patients will receive a bone marrow derived mononuclear cell injection of 4 * 10e8 cells in the m.
biceps brachii.
|
|
Experimental: B
|
650 ml bone marrow will be aspirated from the posterior iliac crest under general anesthesia in combination with a muscle tendon transposition surgery.
Next, the patients will receive a bone marrow derived mononuclear cell injection of 8 * 10e8 cells in the m.
biceps brachii.
|
|
No Intervention: C
|
Patients will receive a muscle tendon transposition surgery without bone marrow aspiration or mononuclear cell injection.
|
What is the study measuring?
Primary Outcome Measures
Primary Outcome Measures
Outcome Measure |
Time Frame |
|---|---|
|
To assess muscle improvement, muscle biopsies, quantitative needle EMGs, muscle density analysis, force measurement, range of motion of the elbow joint and quality of life questionnaires will be performed.
Time Frame: Two years
|
Two years
|
Secondary Outcome Measures
Secondary Outcome Measures
Outcome Measure |
Time Frame |
|---|---|
|
The secondary research aim of this study is to assess vital signs and to detect signs of hematoma and/or injection at the bone marrow aspiration site, injection site and/or surgical wound.
Time Frame: Two years
|
Two years
|
Collaborators and Investigators
Sponsor
Sponsor
Collaborators
Collaborators
Investigators
Investigators
- Principal Investigator: Rob GHH Nelissen, MD, PhD, Leiden University Medical Center
Study record dates
Study Major Dates
Study Start
Study Start
Primary Completion (Anticipated)
Primary Completion
Study Completion (Anticipated)
Study Completion
Study Registration Dates
First Submitted
First Submitted
First Submitted That Met QC Criteria
First Submitted That Met QC Criteria
First Posted (Estimate)
First Posted
Study Record Updates
Last Update Posted (Estimate)
Last Update Posted
Last Update Submitted That Met QC Criteria
Last Update Submitted That Met QC Criteria
Last Verified
Last Verified
More Information
Terms related to this study
Keywords
Other Study ID Numbers
Other Study ID Numbers
- 40-41200-98-040
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.